Home › Soft Tissue Sarcoma › Michigan › Farmington Hills
Soft Tissue Sarcoma clinical trials in Farmington Hills, MI
3 studies for Soft Tissue Sarcoma are looking for participants at sites in and around Farmington Hills (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
RecruitingPhase 2
- Profound Research -OMG - TriAtria Cancer Center, Farmington Hills
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- Corewell Health Farmington Hills Hospital, Farmington Hills
- Henry Ford Health Providence Novi Hospital, Novi · 5 mi away
- Henry Ford Medical Center-Columbus, Novi · 5 mi away
- and 2 more
A Study to Investigate Efficacy & Safety of Intratumoral INT230-6 Compared to US Standard of Care in Adults With Soft Tissue Sarcomas (INVINCIBLE-3)
RecruitingPhase 3
- Profound Research LLC, Farmington Hills
About Soft Tissue Sarcoma
Soft tissue sarcoma refers to cancer that begins in the muscle, fat, vessels or tendons. It can cause a lump or swelling. See which treatments are available
More about Soft Tissue Sarcoma on MedlinePlus
Soft Tissue Sarcoma trials in other cities
- Houston, TX33 studies
- New York City, NY20 studies
- Boston, MA18 studies
- St. Louis, MO14 studies
- Columbus, OH13 studies
- Los Angeles, CA13 studies
- Washington, DC12 studies
- Memphis, TN11 studies
- Philadelphia, PA10 studies
- Nashville, TN9 studies
- Rochester, MN9 studies
- Queens, NY9 studies
Other studies in Farmington Hills
- Parkinson's Disease14 studies
- Non-Small Cell Lung Cancer13 studies
- Obesity12 studies
- Breast Cancer10 studies
- Overweight10 studies
- Heart Failure9 studies
- Alzheimer's Disease8 studies
- Lung Cancer8 studies
- Prostate Cancer8 studies
- Multiple Sclerosis6 studies
- Mild Cognitive Impairment6 studies
- Bladder Cancer6 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.